Author: admin

  • Industry-sponsored mini-sessions

    Six mini-sessions will be hosted by our Gold Sponsors, featuring renowned invited speakers.

    The programmes from Novo Nordisk, Takeda and Pfizer are now available, covering topics such as novel treatment strategies and perioperative management in haemophilia B, von Willebrand disease throughout life, and Marstacimab OLE updates with practical clinical insights from the treatment centre.

    Additional session programmes will be announced in due course.

  • Abstract deadline extended

    30 June is the last day to submit an abstract to NordCoag 2026 in Stockholm — don’t miss the opportunity!

    Abstract submitters are offered the same registration fee as the early bird rate. Younger colleagues are especially encouraged to attend NordCoag 2026 and present their work.